UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cardiovascular research, ISSN 0008-6363, 12/2020, Volume 116, Issue 14, pp. e212 - e214
Journal Article
European heart journal, ISSN 0195-668X, 08/2019, Volume 40, Issue 32, pp. 2668 - 2668
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 375, Issue 9729, pp. 1875 - 1884
Internal Medicine | EXTREMITY ARTERIAL-DISEASE | DENSITY-LIPOPROTEIN CHOLESTEROL | FENOFIBRATE | RISK | HDL CHOLESTEROL | RANDOMIZED CONTROLLED-TRIAL | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | ATHEROSCLEROSIS INTERVENTION | SECONDARY PREVENTION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Cardiovascular Diseases - complications | Clofibric Acid - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Cardiovascular Diseases - mortality | Treatment Outcome | Hypolipidemic Agents - therapeutic use | Randomized Controlled Trials as Topic | Clinical trials | Cardiovascular disease | Drug therapy | Mortality | Morbidity | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9668, pp. 1009 - 1015
Internal Medicine | QUALITY | RAMIPRIL | CLINICAL-TRIALS | HEMODIALYSIS-PATIENTS | PREVENTION | PROSPECTIVELY-DESIGNED OVERVIEWS | CHRONIC KIDNEY-DISEASE | FOLIC-ACID | UMCG Approved | STAGE RENAL-DISEASE | ENZYME-INHIBITOR | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Comorbidity | Cardiovascular Diseases - prevention & control | Humans | Survival Rate | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - etiology | Renal Dialysis - mortality | Diet, Sodium-Restricted | Renal Dialysis - adverse effects | Cardiovascular Diseases - epidemiology | Hypertension - epidemiology | Hypertension - therapy | Causality | Prevention | Control | Hemodialysis patients | Blood pressure | Research | Cardiovascular diseases | Health aspects | Risk factors | Studies | Medical research | Hemodialysis | Mortality | Clinical trials | Cardiovascular disease | Drug therapy | Meta-analysis | Index Medicus | Abridged Index Medicus
Journal Article
European journal of epidemiology, ISSN 0393-2990, 1/2011, Volume 26, Issue 6, pp. 433 - 438
Ratios | Infinity | Angiotensin converting enzyme inhibitors | Drug interactions | Predisposing factors | Diabetes | Type 2 diabetes mellitus | Epidemiology | METHODS | Genotypes | Confidence interval | Relative excess risk due to interaction | Synergy index | Medicine & Public Health | Interaction | Infectious Diseases | Oncology | Public Health/Gesundheitswesen | Preventive factors | Cardiology | Life Sciences & Biomedicine | Public, Environmental & Occupational Health | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Miscellaneous | Prevention and actions | Biological and medical sciences | Medical sciences | Epidemiologic Research Design | Risk Assessment - methods | Data Interpretation, Statistical | Primary Prevention | Humans | Risk Factors | Causality | Case-Control Studies | Risk Assessment - statistics & numerical data | Public health | Risk factors | Estimating techniques | Index Medicus | Life Sciences | Santé publique et épidémiologie | Methods
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 371, Issue 9618, pp. 1085 - 1097
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sulpiride - therapeutic use | Humans | Quetiapine Fumarate | Proportional Hazards Models | Haloperidol - therapeutic use | Linear Models | Male | Treatment Outcome | Piperazines - therapeutic use | Thiazoles - therapeutic use | Sulpiride - analogs & derivatives | Dibenzothiazepines - therapeutic use | Antipsychotic Agents - therapeutic use | Adolescent | Adult | Female | Patient Compliance | Schizophrenia - drug therapy | Benzodiazepines - therapeutic use | Schizophrenia | Evaluation | Antipsychotic drugs | Schizophreniform disorder | Drug therapy | Psychotropic drugs | Studies | Neurosciences | Effectiveness | Clinical trials | Psychopathology | Clinical medicine | Pharmaceutical industry | Quality of life | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Global heart, ISSN 2211-8160, 01/2020, Volume 15, Issue 1, pp. 24 - 24
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | COVID-19 | Coronavirus Infections | Cardiovascular Diseases | SARS-CoV-2 | Pandemics | Humans | Betacoronavirus | Pneumonia, Viral | Cardiology | Periodicals as Topic | Index Medicus | coronavirus | cardiology
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 2013, Volume 310, Issue 9, pp. 918 - 929
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Medication Adherence - statistics & numerical data | Simvastatin - administration & dosage | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - adverse effects | Aspirin - administration & dosage | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Combinations | Lisinopril - administration & dosage | Clinical trials | Cardiovascular disease | Blood pressure | Patients | Risk factors
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 370, Issue 9582, pp. 153 - 160
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Carotid Arteries - drug effects | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Heptanoic Acids - adverse effects | Anticholesteremic Agents - adverse effects | Tunica Intima - drug effects | Atorvastatin Calcium | Dyslipidemias - blood | Anticholesteremic Agents - therapeutic use | Tunica Intima - pathology | Pyrroles - adverse effects | Female | Blood Pressure - drug effects | Quinolines - therapeutic use | Pyrroles - therapeutic use | Quinolines - adverse effects | Studies | Medical research | Digital imaging | Diet | Mortality | Cardiovascular disease | Metabolic syndrome | Protocol | Low density lipoprotein | Patients | Cholesterol | Veins & arteries | Lipoproteins (low density) | Laboratories | Clinical trials | Segments | Density | Evidence-based medicine | Carotid arteries | Blood | Proteins | Randomization | Ultrasonic imaging | Radiance | Atherosclerosis | Blood pressure | Lipoproteins (high density) | Ultrasound | Media | Triglycerides | Cholesteryl ester transfer protein | Arteriosclerosis | Atorvastatin | Titration | Diabetes | Health risk assessment | Mercury | Index Medicus | Abridged Index Medicus
Journal Article
10.
Full Text
Risk prediction models: II. External validation, model updating, and impact assessment
Heart (British Cardiac Society), ISSN 1355-6037, 05/2012, Volume 98, Issue 9, pp. 691 - 698
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Decision Making | Models, Theoretical | Risk Assessment - methods | Reproducibility of Results | Prognosis | Delivery of Health Care - organization & administration | Humans | Cardiovascular Diseases - therapy | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - diagnosis | Research validity | Care and treatment | Models | Cardiovascular diseases | Health risk assessment | Analysis | Performance evaluation | Hospitals | Cost analysis | Decision making | Validation studies | Index Medicus | Abridged Index Medicus
Journal Article